2022 Q4 Form 10-Q Financial Statement

#000107261322000628 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $17.00M
YoY Change -100.0% 309.64%
Cost Of Revenue $0.00 $0.00 $6.610M
YoY Change -100.0% -100.0% 314.94%
Gross Profit $0.00 $0.00 $10.39M
YoY Change -100.0% -100.0% 306.34%
Gross Profit Margin 61.12%
Selling, General & Admin $1.251M $756.0K $1.279M
YoY Change 29.37% -40.89% 55.03%
% of Gross Profit 12.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $83.00K $82.00K $74.00K
YoY Change 12.16% 10.81% 2.78%
% of Gross Profit 0.71%
Operating Expenses $1.334M $838.0K $1.353M
YoY Change 28.15% -38.06% 50.84%
Operating Profit -$1.334M -$838.0K $9.037M
YoY Change 62.48% -109.27% 444.4%
Interest Expense $651.0K $3.780M $27.00K
YoY Change 65000.0% 13900.0% -84.39%
% of Operating Profit 0.3%
Other Income/Expense, Net $4.051M $27.00K
YoY Change 14903.7%
Pretax Income -$683.0K $3.213M $9.064M
YoY Change -16.71% -64.55% 394.49%
Income Tax $459.0K $702.0K $2.289M
% Of Pretax Income 21.85% 25.25%
Net Earnings -$1.708M $2.226M $6.589M
YoY Change 75.0% -66.22% 290.57%
Net Earnings / Revenue 38.76%
Basic Earnings Per Share $0.09 $0.28
Diluted Earnings Per Share -$0.07 $0.09 $270.9K
COMMON SHARES
Basic Shares Outstanding 23.89M shares 23.77M shares 23.93M shares
Diluted Shares Outstanding 24.07M shares 24.32M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.44M $48.92M $60.84M
YoY Change -18.76% -19.59% 33.74%
Cash & Equivalents $13.45M $21.16M $43.17M
Short-Term Investments $34.99M $27.76M $17.67M
Other Short-Term Assets $348.0K $108.0K $26.00K
YoY Change 132.0% 315.38% -13.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $48.96M $49.37M $60.87M
YoY Change -18.08% -18.89% 33.71%
LONG-TERM ASSETS
Property, Plant & Equipment $161.0K $177.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.252M $7.661M $4.018M
YoY Change 173.56% 90.67% 5.93%
Other Assets $0.00 $13.00K $13.00K
YoY Change -100.0% 0.0% -38.1%
Total Long-Term Assets $9.005M $9.526M $5.475M
YoY Change 78.39% 73.99% 0.15%
TOTAL ASSETS
Total Short-Term Assets $48.96M $49.37M $60.87M
Total Long-Term Assets $9.005M $9.526M $5.475M
Total Assets $57.97M $58.89M $66.34M
YoY Change -10.57% -11.23% 30.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $507.0K $348.0K $399.0K
YoY Change 10.46% -12.78% 470.0%
Accrued Expenses $983.0K $460.0K $180.0K
YoY Change 41.03% 155.56% -34.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.605M $812.0K $3.615M
YoY Change -60.93% -77.54% 950.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $94.00K $111.0K
YoY Change
Total Long-Term Liabilities $94.00K $111.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.605M $812.0K $3.615M
Total Long-Term Liabilities $94.00K $111.0K $0.00
Total Liabilities $2.860M $1.899M $4.295M
YoY Change -38.65% -55.79% 1148.55%
SHAREHOLDERS EQUITY
Retained Earnings -$12.06M -$9.996M
YoY Change 87.54%
Common Stock $239.0K $237.0K
YoY Change 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.11M $56.99M $62.05M
YoY Change
Total Liabilities & Shareholders Equity $57.97M $58.89M $66.34M
YoY Change -10.57% -11.23% 30.11%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.708M $2.226M $6.589M
YoY Change 75.0% -66.22% 290.57%
Depreciation, Depletion And Amortization $83.00K $82.00K $74.00K
YoY Change 12.16% 10.81% 2.78%
Cash From Operating Activities -$256.0K -$572.0K $8.331M
YoY Change 150.98% -106.87% 282.16%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$19.00K
YoY Change -100.0% -100.0% 72.73%
Acquisitions
YoY Change
Other Investing Activities -$7.033M -$2.435M -$2.985M
YoY Change -392.92% -18.43% -222.64%
Cash From Investing Activities -$7.033M -$2.435M -$3.004M
YoY Change -394.76% -18.94% -223.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -427.0K -1.361M -1.204M
YoY Change -55.52% 13.04% -11.08%
NET CHANGE
Cash From Operating Activities -256.0K -572.0K 8.331M
Cash From Investing Activities -7.033M -2.435M -3.004M
Cash From Financing Activities -427.0K -1.361M -1.204M
Net Change In Cash -7.716M -4.368M 4.123M
YoY Change -682.78% -205.94% 26.9%
FREE CASH FLOW
Cash From Operating Activities -$256.0K -$572.0K $8.331M
Capital Expenditures $0.00 $0.00 -$19.00K
Free Cash Flow -$256.0K -$572.0K $8.350M
YoY Change 194.25% -106.85% 281.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001065078
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 nssi Convertible Note Investments
ConvertibleNoteInvestments
usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q3 nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
usd
nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
usd
CY2022Q1 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2022Q2 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2022Q3 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2021Q1 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2021Q2 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
CY2021Q3 nssi Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
usd
nssi Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
usd
nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
usd
nssi Accrued Interest On Convertible Note
AccruedInterestOnConvertibleNote
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
nssi Convertible Note Investment
ConvertibleNoteInvestment
usd
nssi Value Of Shares Delivered To Fund Withholding Taxes
ValueOfSharesDeliveredToFundWithholdingTaxes
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
nssi Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
usd
nssi Non Cash Conversion Of Note Receivable
NonCashConversionOfNoteReceivable
usd
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
nssi Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive
OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive
shares
CY2022Q3 nssi Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive
OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive
shares
CY2021Q3 nssi Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive
OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive
shares
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
usd
us-gaap Operating Lease Cost
OperatingLeaseCost
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-15288
dei Entity Registrant Name
EntityRegistrantName
NETWORK-1 TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3027591
dei Entity Address Address Line1
EntityAddressAddressLine1
65 Locust Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Third Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New Canaan
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06840
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
920-1055
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
NTIP
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23892772 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21164000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44497000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
27759000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15126000 usd
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
336000 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
10000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
108000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
140000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
49367000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
59773000 usd
CY2022Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1675000 usd
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1384000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
7661000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2651000 usd
CY2021Q4 nssi Convertible Note Investments
ConvertibleNoteInvestments
1000000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
177000 usd
CY2022Q3 us-gaap Security Deposit
SecurityDeposit
13000 usd
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
13000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
9526000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
5048000 usd
CY2022Q3 us-gaap Assets
Assets
58893000 usd
CY2021Q4 us-gaap Assets
Assets
64821000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
4000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2952000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
348000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
459000 usd
CY2022Q3 nssi Accrued Contingency Fees And Related Costs
AccruedContingencyFeesAndRelatedCosts
35000 usd
CY2021Q4 nssi Accrued Contingency Fees And Related Costs
AccruedContingencyFeesAndRelatedCosts
137000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
380000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
327000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
180000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
812000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4108000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
976000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
554000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
111000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1899000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4662000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23727231 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23727231 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23792212 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23792212 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
237000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
238000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66767000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66361000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9996000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6428000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
56994000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
60159000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58893000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64821000 usd
CY2021Q3 us-gaap Revenues
Revenues
17000000 usd
us-gaap Revenues
Revenues
35692000 usd
CY2021Q3 nssi Cost Of Revenues
CostOfRevenues
6610000 usd
nssi Cost Of Revenues
CostOfRevenues
12030000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
117000 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
721000 usd
us-gaap Professional Fees
ProfessionalFees
524000 usd
us-gaap Professional Fees
ProfessionalFees
1384000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
639000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
558000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1812000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1650000 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
82000 usd
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
74000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
233000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
221000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
838000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
7963000 usd
us-gaap Operating Expenses
OperatingExpenses
2569000 usd
us-gaap Operating Expenses
OperatingExpenses
15285000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-838000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9037000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2569000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
20407000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
321000 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
67000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
532000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
185000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
CY2022Q3 nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
3727000 usd
nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
3727000 usd
CY2022Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-268000 usd
CY2021Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-40000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-1358000 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-32000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4051000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3172000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
153000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
3213000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
9064000 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
603000 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
20560000 usd
CY2022Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-274000 usd
CY2021Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2326000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-274000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3036000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
976000 usd
CY2021Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-37000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
422000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1635000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
702000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2289000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4671000 usd
CY2022Q3 nssi Loss Income Before Share Of Net Losses Of Equity Method Investee
LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee
2511000 usd
CY2021Q3 nssi Loss Income Before Share Of Net Losses Of Equity Method Investee
LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee
6775000 usd
nssi Loss Income Before Share Of Net Losses Of Equity Method Investee
LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee
455000 usd
nssi Loss Income Before Share Of Net Losses Of Equity Method Investee
LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee
15889000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-285000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-186000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-1073000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-632000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2226000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6589000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Net Income Loss
NetIncomeLoss
15257000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23765089 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23934361 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23830702 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24136506 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24065724 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24320231 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23830702 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24607242 shares
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2226000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6589000 usd
us-gaap Net Income Loss
NetIncomeLoss
-618000 usd
us-gaap Net Income Loss
NetIncomeLoss
15257000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
2000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-4000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
4000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2228000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6585000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-620000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15261000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
60159000 usd
CY2022Q1 nssi Dividends And Dividend Equivalents Declared
DividendsAndDividendEquivalentsDeclared
-1190000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000 usd
CY2022Q1 nssi Value Of Shares Delivered To Pay Withholding Taxes
ValueOfSharesDeliveredToPayWithholdingTaxes
-112000 usd
CY2022Q1 nssi Net Unrealized Loss On Corporate Bonds And Notes
NetUnrealizedLossOnCorporateBondsAndNotes
-3000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1312000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
57597000 usd
CY2022Q2 nssi Dividends And Dividend Equivalents Declared
DividendsAndDividendEquivalentsDeclared
-5000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
178000 usd
CY2022Q2 nssi Treasury Stock Purchased And Retired
TreasuryStockPurchasedAndRetired
-247000 usd
CY2022Q2 nssi Net Unrealized Loss On Corporate Bonds And Notes
NetUnrealizedLossOnCorporateBondsAndNotes
-1000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1532000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
55990000 usd
CY2022Q3 nssi Dividends And Dividend Equivalents Declared
DividendsAndDividendEquivalentsDeclared
-1223000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
174000 usd
CY2022Q3 nssi Treasury Stock Purchased And Retired
TreasuryStockPurchasedAndRetired
-175000 usd
CY2022Q3 nssi Net Unrealized Loss On Corporate Bonds And Notes
NetUnrealizedLossOnCorporateBondsAndNotes
2000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
2226000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
56994000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
49162000 usd
CY2021Q1 nssi Dividends And Dividend Equivalents Declared
DividendsAndDividendEquivalentsDeclared
-1216000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59000 usd
CY2021Q1 nssi Net Unrealized Loss On Corporate Bonds And Notes
NetUnrealizedLossOnCorporateBondsAndNotes
11000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9451000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
57467000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59000 usd
CY2021Q2 nssi Treasury Stock Purchased And Retired
TreasuryStockPurchasedAndRetired
-131000 usd
CY2021Q2 nssi Net Unrealized Loss On Corporate Bonds And Notes
NetUnrealizedLossOnCorporateBondsAndNotes
-3000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-783000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
56609000 usd
CY2021Q3 nssi Dividends And Dividend Equivalents Declared
DividendsAndDividendEquivalentsDeclared
-1213000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
6589000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
62046000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
618000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15257000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
233000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
221000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
407000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
183000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-1073000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-632000 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
422000 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1634000 usd
nssi Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
27000 usd
nssi Gain On Equity Method Investment
GainOnEquityMethodInvestment
3727000 usd
nssi Accrued Interest On Convertible Note
AccruedInterestOnConvertibleNote
86000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1079000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-9000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-32000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-94000 usd
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
326000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-110000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-197000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2948000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3036000 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
8000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-346000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1276000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5180000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19601000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-8750000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-12291000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
22464000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10597000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
524000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
86000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000 usd
nssi Convertible Note Investment
ConvertibleNoteInvestment
1000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15238000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
608000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2381000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2410000 usd
nssi Value Of Shares Delivered To Fund Withholding Taxes
ValueOfSharesDeliveredToFundWithholdingTaxes
112000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
422000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
131000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2915000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2541000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-23333000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17668000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44497000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25505000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21164000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43173000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3165000 usd
nssi Accrued Dividend Rights On Restricted Stock Units
AccruedDividendRightsOnRestrictedStockUnits
37000 usd
nssi Accrued Dividend Rights On Restricted Stock Units
AccruedDividendRightsOnRestrictedStockUnits
19000 usd
nssi Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
204000 usd
nssi Non Cash Conversion Of Note Receivable
NonCashConversionOfNoteReceivable
1086000 usd
us-gaap Gain Contingency Patents Found Infringed Upon Number
GainContingencyPatentsFoundInfringedUponNumber
96 integer
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
3727000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
3727000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
74000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
233000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
221000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zczbRF4WhB1c" style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span> </span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z3nyPI1gkyB7">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s unaudited condensed consolidated financial statements include legal fees and related costs, income taxes, valuation of patents, and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.</span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2597000 usd
CY2022Q3 us-gaap Cash
Cash
16721000 usd
CY2021Q4 us-gaap Cash
Cash
33385000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
319000 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
803000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
533000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1246000 usd
CY2022Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
976000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8473000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7949000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6798000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6565000 usd
CY2022Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1675000 usd
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1384000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
82000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
120000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
120000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
120000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
120000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
876000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1675000 usd
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
12500 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.36
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
670000 shares
nssi Issuance Weightedaverage Grant Date Fair Value
IssuanceWeightedaverageGrantDateFairValue
1.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
33750 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.55
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
648750 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.91
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1148750 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
548750 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23830702 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24136506 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23765089 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23934361 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
470736 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
300635 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
385870 shares
nssi Weightedaverage Common Shares Outstanding Diluted
WeightedaverageCommonSharesOutstandingDiluted
23830702 shares
nssi Weightedaverage Common Shares Outstanding Diluted
WeightedaverageCommonSharesOutstandingDiluted
24607242 shares
CY2022Q3 nssi Weightedaverage Common Shares Outstanding Diluted
WeightedaverageCommonSharesOutstandingDiluted
24065724 shares
CY2021Q3 nssi Weightedaverage Common Shares Outstanding Diluted
WeightedaverageCommonSharesOutstandingDiluted
24320231 shares
nssi Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive
OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive
1148750 shares
CY2022Q1 nssi Hft Patent Acqusition Cash At Closing
HftPatentAcqusitionCashAtClosing
500000 usd
CY2022Q1 nssi Obligation To Pay Hft Seller Additional Cash Based On Achieving Certain Milestones
ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones
500000 usd
CY2022Q1 nssi Contingent Common Stock Issued Upon Achieving Certain Milestones
ContingentCommonStockIssuedUponAchievingCertainMilestones
375000 usd
CY2022Q1 nssi First50 Million
First50Million
0.15 pure
CY2022Q1 nssi Greater Than50 Million
GreaterThan50Million
0.175 pure
CY2022Q3 nssi Obligated To Pay Seller Net Proceed Percentage
ObligatedToPaySellerNetProceedPercentage
0.125 pure
CY2022Q3 nssi First125 Million
First125Million
0.10 pure
CY2022Q3 nssi Next125 Million
Next125Million
0.15 pure
CY2022Q3 nssi Over250 Million
Over250Million
0.20 pure
nssi Recognition Net Proceeds Payment Related To Mirror Worlds Patents
RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents
3127000 usd
CY2022Q3 nssi First100
First100
0.14 pure
CY2022Q3 nssi Next100
Next100
0.05 pure
CY2022Q3 nssi Aadditional Consideration
AadditionalConsideration
250000 usd
CY2022Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.042 pure
CY2022Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y7M6D
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
177000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
111000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
183000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
18000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
30000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000 usd
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
30000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
46000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
86000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
28000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
30000 usd
us-gaap Lease Cost
LeaseCost
76000 usd
us-gaap Lease Cost
LeaseCost
86000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
24000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
73000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
73000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
24000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
194000 usd
CY2022Q3 nssi Operating Leases Imputed Interest
OperatingLeasesImputedInterest
-11000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
183000 usd
CY2022Q3 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
3727000 usd
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
3727000 usd
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1000000 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
86000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
271000 usd
CY2021Q2 nssi Stock Repurchase Program Dollar Amount That May Be Repurchased
StockRepurchaseProgramDollarAmountThatMayBeRepurchased
5000000 usd
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
9162427 shares
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
17647631 usd
nssi Weighted Average Price Per Share Common Stock Subject To Repurchase
WeightedAveragePricePerShareCommonStockSubjectToRepurchase
1.93
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
75213 shares
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
174530 usd
CY2022Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
2.32
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
178293 shares
CY2022Q3 nssi Royalty Receivables
RoyaltyReceivables
0 usd
CY2021Q4 nssi Royalty Receivables
RoyaltyReceivables
0 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
422388 usd
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
2.37
CY2022Q3 nssi Value Of Remaining Shares That May Be Repurchased
ValueOfRemainingSharesThatMayBeRepurchased
3508374 usd
nssi Dividends Per Share
DividendsPerShare
0.05
nssi Dividends Per Share Annual
DividendsPerShareAnnual
0.10

Files In Submission

Name View Source Status
0001072613-22-000628-index-headers.html Edgar Link pending
0001072613-22-000628-index.html Edgar Link pending
0001072613-22-000628.txt Edgar Link pending
0001072613-22-000628-xbrl.zip Edgar Link pending
exh31-1_18670.htm Edgar Link pending
exh31-2_18670.htm Edgar Link pending
exh32-1_18670.htm Edgar Link pending
exh32-2_18670.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
network1_10q-093022.htm Edgar Link pending
nssi-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
nssi-20220930_cal.xml Edgar Link unprocessable
nssi-20220930_def.xml Edgar Link unprocessable
nssi-20220930_lab.xml Edgar Link unprocessable
nssi-20220930_pre.xml Edgar Link unprocessable
network1_10q-093022_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable